Leon Cooperman’s Omega Advisors picked up a handful of little-known names that took a hit during the fourth quarter of 2024, regulatory fillings show. The billionaire investor increased stakes in WillScot Holdings , Ashland and Elevance Health in the final three-month period of 2024, according to Omega’s 13-F document. With those increases, all three names were now among the fund’s top 10 largest holdings, as of the end of last quarter. Cooperman upped his position in storage company WillScot Holdings by about $14 million, or 10.5%, to more than $130 million. The stock is now the firm’s fifth largest position, data from InsiderScore shows. The Omega CEO and founder’s move offers a vote of confidence in a stock that’s been under pressure. It dropped 11% in the forth quarter, marking its third straight negative quarter. However, shares have rallied more than 12% in 2025. The Goldman Sachs alum also hiked his Ashland holding by more than 33%, or $29 million, to nearly $104 million. With that, the chemical company sits in the position of Omega’s ninth largest position, according to InsiderScore. Ashland tumbled close to 18% in the fourth quarter, also notching its third down quarter in a row. Unlike WillScot, Ashland has dropped another 9.2% in the first quarter of 2025. ASH ELV,WSC 1Y mountain Ashland, Elevance and WillScot shares over the past year Finally, Elevance Health was the fund’s 10th largest position at the end of 2024, per InsiderScore. In the fourth quarter, Cooperman added nearly 63%, or $50 million, to make his holding valued at more than $102 million. Similar to the other names, the health insurer plunged just over 29% in the fourth quarter, building on the prior three-month period’s 4% slide. But shares have made up some ground in 2025, climbing more than 5%. While these stocks struggled, Wall Street is optimistic. Half of more of analysts polled by LSEG hold buy ratings on each name, with average price targets suggesting upsides ahead for all three stocks.
Leon Cooperman bought these under-the-radar stocks that struggled during the fourth quarter